We are committed to gaining a better understanding of disease pathology in order to inform more precise diagnostic and treatment methods. Rather than examining hallmarks in a reductionist fashion, we aim to illuminate how spatiotemporal and environmental aspects impact molecular and metabolic changes.
We aim to develop a comprehensive diagnostic panel to guide clinical treatment decisions in patients with complex chronic conditions like long COVID, ME/CFS, MCAS, and fibromyalgia. By analyzing genomics, metabolomics, and immune profiling, we can uncover hidden patterns and biomarkers that can aid in diagnosis and treatment planning.
No two patients are alike. Most commercial drugs have an exceptionally high number needed to treat (NNT), resulting in inefficient medicine riddled with side effects.
Our precision diagnostics and treatment approach involves analyzing multiple data types (multiomics, microbiome, immune status) in order to:
construct "digital twins" of patients
stratify patients by phenotype
recommend personalized therapies
improve clinical outcomes
“Nothing in life is to be feared, only understood. Now is the time to understand more so that we may fear less.” - Marie Curie